Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.03
MWIV's Cash to Debt is ranked lower than
59% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.69 vs. MWIV: 0.03 )
MWIV' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: 0.03

Equity to Asset 0.52
MWIV's Equity to Asset is ranked higher than
78% of the 65 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.42 vs. MWIV: 0.52 )
MWIV' s 10-Year Equity to Asset Range
Min: 0.05   Max: 0.64
Current: 0.52

0.05
0.64
Interest Coverage 99.29
MWIV's Interest Coverage is ranked higher than
79% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.02 vs. MWIV: 99.29 )
MWIV' s 10-Year Interest Coverage Range
Min: 2.06   Max: 167.2
Current: 99.29

2.06
167.2
F-Score: 5
Z-Score: 7.41
M-Score: -2.37
WACC vs ROIC
1.98%
12.98%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 3.89
MWIV's Operating margin (%) is ranked higher than
71% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.77 vs. MWIV: 3.89 )
MWIV' s 10-Year Operating margin (%) Range
Min: 2.57   Max: 4.41
Current: 3.89

2.57
4.41
Net-margin (%) 2.38
MWIV's Net-margin (%) is ranked higher than
68% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.25 vs. MWIV: 2.38 )
MWIV' s 10-Year Net-margin (%) Range
Min: 0.64   Max: 2.72
Current: 2.38

0.64
2.72
ROE (%) 15.17
MWIV's ROE (%) is ranked higher than
82% of the 61 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.91 vs. MWIV: 15.17 )
MWIV' s 10-Year ROE (%) Range
Min: 9.98   Max: 351.09
Current: 15.17

9.98
351.09
ROA (%) 7.48
MWIV's ROA (%) is ranked higher than
86% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.21 vs. MWIV: 7.48 )
MWIV' s 10-Year ROA (%) Range
Min: 1.88   Max: 8.91
Current: 7.48

1.88
8.91
ROC (Joel Greenblatt) (%) 26.93
MWIV's ROC (Joel Greenblatt) (%) is ranked higher than
74% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.12 vs. MWIV: 26.93 )
MWIV' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 22.4   Max: 53.64
Current: 26.93

22.4
53.64
Revenue Growth (3Y)(%) 23.20
MWIV's Revenue Growth (3Y)(%) is ranked higher than
91% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.50 vs. MWIV: 23.20 )
MWIV' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0   Max: 29
Current: 23.2

0
29
EBITDA Growth (3Y)(%) 19.30
MWIV's EBITDA Growth (3Y)(%) is ranked higher than
80% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.10 vs. MWIV: 19.30 )
MWIV' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 27.9
Current: 19.3

0
27.9
EPS Growth (3Y)(%) 18.40
MWIV's EPS Growth (3Y)(%) is ranked higher than
73% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.30 vs. MWIV: 18.40 )
MWIV' s 10-Year EPS Growth (3Y)(%) Range
Min: 0   Max: 64.7
Current: 18.4

0
64.7
» MWIV's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

MWIV Guru Trades in Q1 2014

Paul Tudor Jones 4,600 sh (New)
Steven Cohen 1,769 sh (New)
Chuck Royce 10,000 sh (unchged)
Joel Greenblatt Sold Out
Mario Gabelli 50,400 sh (-1.37%)
Jim Simons 9,100 sh (-63.89%)
» More
Q2 2014

MWIV Guru Trades in Q2 2014

Ron Baron 152,873 sh (New)
Chuck Royce 10,000 sh (unchged)
Jim Simons Sold Out
Mario Gabelli 48,200 sh (-4.37%)
Paul Tudor Jones 2,400 sh (-47.83%)
» More
Q3 2014

MWIV Guru Trades in Q3 2014

Jeremy Grantham 10,599 sh (New)
Ron Baron 288,997 sh (+89.04%)
Chuck Royce 10,000 sh (unchged)
Paul Tudor Jones Sold Out
Mario Gabelli 47,200 sh (-2.07%)
» More
Q4 2014

MWIV Guru Trades in Q4 2014

Ron Baron 315,300 sh (+9.1%)
Chuck Royce 10,000 sh (unchged)
Mario Gabelli 46,400 sh (-1.69%)
Jeremy Grantham 7,900 sh (-25.46%)
» More
» Details

Insider Trades

Latest Guru Trades with MWIV

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ron Baron 2014-09-30 Add 89.04%0.08%$136.5 - $149.53 $ 19032%288997
Ron Baron 2014-06-30 New Buy0.09%$131.12 - $164.08 $ 19029%152873
Joel Greenblatt 2014-03-31 Sold Out 0.03%$150.5 - $186.26 $ 19013%0
Joel Greenblatt 2013-12-31 Reduce -35.39%0.02%$151.43 - $182.17 $ 19014%7647
Joel Greenblatt 2013-09-30 New Buy0.06%$119.35 - $155.01 $ 19034%11835
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 32.90
MWIV's P/E(ttm) is ranked higher than
64% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 26.40 vs. MWIV: 32.90 )
MWIV' s 10-Year P/E(ttm) Range
Min: 12.17   Max: 43.24
Current: 32.9

12.17
43.24
Forward P/E 25.84
MWIV's Forward P/E is ranked higher than
77% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 55.87 vs. MWIV: 25.84 )
N/A
PE(NRI) 32.90
MWIV's PE(NRI) is ranked higher than
64% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 26.70 vs. MWIV: 32.90 )
MWIV' s 10-Year PE(NRI) Range
Min: 12.17   Max: 43.08
Current: 32.9

12.17
43.08
P/B 4.72
MWIV's P/B is ranked higher than
60% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.68 vs. MWIV: 4.72 )
MWIV' s 10-Year P/B Range
Min: 1.35   Max: 5.49
Current: 4.72

1.35
5.49
P/S 0.78
MWIV's P/S is ranked higher than
75% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.78 vs. MWIV: 0.78 )
MWIV' s 10-Year P/S Range
Min: 0.3   Max: 0.99
Current: 0.78

0.3
0.99
PFCF 36.19
MWIV's PFCF is ranked higher than
74% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 55.13 vs. MWIV: 36.19 )
MWIV' s 10-Year PFCF Range
Min: 15.63   Max: 1329.67
Current: 36.19

15.63
1329.67
POCF 28.83
MWIV's POCF is ranked higher than
67% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 21.00 vs. MWIV: 28.83 )
MWIV' s 10-Year POCF Range
Min: 14.68   Max: 250.71
Current: 28.83

14.68
250.71
EV-to-EBIT 20.96
MWIV's EV-to-EBIT is ranked higher than
68% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.02 vs. MWIV: 20.96 )
MWIV' s 10-Year EV-to-EBIT Range
Min: 7.5   Max: 24
Current: 20.96

7.5
24
PEG 1.44
MWIV's PEG is ranked higher than
86% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.81 vs. MWIV: 1.44 )
MWIV' s 10-Year PEG Range
Min: 0.72   Max: 1.6
Current: 1.44

0.72
1.6
Shiller P/E 46.35
MWIV's Shiller P/E is ranked higher than
73% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 40.54 vs. MWIV: 46.35 )
MWIV' s 10-Year Shiller P/E Range
Min: 27.99   Max: 55.37
Current: 46.35

27.99
55.37
Current Ratio 1.71
MWIV's Current Ratio is ranked higher than
77% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.50 vs. MWIV: 1.71 )
MWIV' s 10-Year Current Ratio Range
Min: 1.07   Max: 2.29
Current: 1.71

1.07
2.29
Quick Ratio 0.82
MWIV's Quick Ratio is ranked higher than
55% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.06 vs. MWIV: 0.82 )
MWIV' s 10-Year Quick Ratio Range
Min: 0.59   Max: 1.26
Current: 0.82

0.59
1.26
Days Inventory 55.03
MWIV's Days Inventory is ranked higher than
68% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 52.56 vs. MWIV: 55.03 )
MWIV' s 10-Year Days Inventory Range
Min: 22.83   Max: 54.62
Current: 55.03

22.83
54.62
Days Sales Outstanding 39.36
MWIV's Days Sales Outstanding is ranked higher than
82% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 56.12 vs. MWIV: 39.36 )
MWIV' s 10-Year Days Sales Outstanding Range
Min: 43.93   Max: 59.92
Current: 39.36

43.93
59.92

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 6.37
MWIV's Price/Tangible Book is ranked higher than
77% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.28 vs. MWIV: 6.37 )
MWIV' s 10-Year Price/Tangible Book Range
Min: 2.35   Max: 6.61
Current: 6.37

2.35
6.61
Price/DCF (Projected) 3.08
MWIV's Price/DCF (Projected) is ranked higher than
77% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.07 vs. MWIV: 3.08 )
MWIV' s 10-Year Price/DCF (Projected) Range
Min: 2.13   Max: 4.56
Current: 3.08

2.13
4.56
Price/Median PS Value 1.29
MWIV's Price/Median PS Value is ranked higher than
73% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.31 vs. MWIV: 1.29 )
MWIV' s 10-Year Price/Median PS Value Range
Min: 0.57   Max: 1.44
Current: 1.29

0.57
1.44
Price/Peter Lynch Fair Value 1.60
MWIV's Price/Peter Lynch Fair Value is ranked higher than
88% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.00 vs. MWIV: 1.60 )
MWIV' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.74   Max: 1.43
Current: 1.6

0.74
1.43
Price/Graham Number 3.08
MWIV's Price/Graham Number is ranked higher than
78% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.06 vs. MWIV: 3.08 )
MWIV' s 10-Year Price/Graham Number Range
Min: 1.27   Max: 3.5
Current: 3.08

1.27
3.5
Earnings Yield (Greenblatt) 4.80
MWIV's Earnings Yield (Greenblatt) is ranked higher than
65% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.70 vs. MWIV: 4.80 )
MWIV' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.2   Max: 13.4
Current: 4.8

4.2
13.4
Forward Rate of Return (Yacktman) 21.80
MWIV's Forward Rate of Return (Yacktman) is ranked higher than
86% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.49 vs. MWIV: 21.80 )
MWIV' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 15.9   Max: 28.4
Current: 21.8

15.9
28.4

Analyst Estimate

Sep15 Sep16 Sep17
Revenue(Mil) 3,340 3,689 4,054
EPS($) 6.38 7.34 8.80
EPS without NRI($) 6.38 7.34 8.80

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, MCK, CAH, SHTDF, HSIC » details
Traded in other countries:M4D.Germany,
MWI Veterinary Supply Inc commenced operations as part of a veterinary practice in 1976 and was incorporated as MWI Drug Supply, Inc., an Idaho corporation, in 1980. The Company is a distributor of animal health products. Its products include pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, supplies, specialty products, veterinary pet food, capital equipment & nutritional products. It markets these products to veterinarians in both the companion animal and production animal markets. It also offers its customers services, including its e-commerce platform, technology management systems, pharmacy fulfillment, inventory management system, equipment procurement consultation, special order fulfillment, educational seminars and pet cremation. As of September 30, 2012, it distributed its products from fourteen strategically located distribution centers throughout the United States and one in the United Kingdom. The Company competes with numerous vendors and distributors based on customer relationships, service and delivery, product selection, price and e-commerce capabilities. Certain of it businesses involve the distribution of pharmaceuticals, and in this regard it is subject to various local, state, federal and foreign governmental laws and regulations applicable to the distribution of pharmaceuticals.
» More Articles for MWIV

Headlines

Articles On GuruFocus.com
MWI Veterinary Supply Announces Postponement of 2015 Annual Meeting of Stockholders Jan 12 2015 
President and CEO of MWI Vet Supply James F. Cleary Jr. Sold 76,394 shares Jun 19 2012 
MWI Veterinary Supply Inc. (MWIV) Senior VP, Secretary and CFO Mary Patricia B Thompson sells 1,000 Mar 03 2011 
MWI Veterinary Supply Inc. (MWIV) Senior VP, Secretary and CFO Mary Patricia B Thompson sells 3,000 Feb 16 2011 
MWI Veterinary Supply Inc. Reports Operating Results (10-Q) Feb 03 2011 
MWI Veterinary Supply Inc. (MWIV) President and CEO James F Jr Cleary sells 25,900 Shares Nov 18 2010 
MWI Veterinary Supply Inc. (MWIV) Senior VP, Secretary and CFO Mary Patricia B Thompson sells 12,000 Sep 22 2010 
MWI Veterinary Supply Inc. (MWIV) Senior VP, Secretary and CFO Mary Patricia B Thompson sells 1,500 Sep 02 2010 
MWI Veterinary Supply Inc. (MWIV) Senior VP, Secretary and CFO Mary Patricia B Thompson sells 1,500 Aug 03 2010 
MWI Veterinary Supply Inc. Reports Operating Results (10-Q) Jul 29 2010 

More From Other Websites
MWI VETERINARY SUPPLY, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Feb 24 2015
Trupanion Selected By MWI Veterinary Supply as Preferred Provider of Medical Insurance for Cats and... Feb 18 2015
Vascular Solutions Set to Join the S&P SmallCap 600 Feb 17 2015
MWI Veterinary: Benefits of Takeover by AmerisourceBergen - Analyst Blog Feb 12 2015
MWI Vet Supply (MWIV): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Feb 12 2015
MWI VETERINARY SUPPLY, INC. Financials Feb 11 2015
AmerisourceBergen Announces Expiration of the Hart-Scott-Rodino Waiting Period for... Feb 11 2015
MWI Veterinary (MWIV) Beats on Q1 Earnings & Revenues - Analyst Blog Feb 09 2015
10-Q for MWI Veterinary Supply, Inc. Feb 07 2015
MWI VETERINARY SUPPLY, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 05 2015
MWI tops Street 1Q forecasts Feb 05 2015
MWI tops Street 1Q forecasts Feb 05 2015
MWI Veterinary Supply Announces 2015 First Quarter Results Feb 05 2015
AmerisourceBergen Beats on Q1 Earnings, Ups 2015 View - Analyst Blog Jan 28 2015
MWI VETERINARY SUPPLY INVESTOR ALERT: Faruqi & Faruqi, LLP is Investigating the Board of Directors... Jan 27 2015
AmerisourceBergen Commences Tender Offer to Acquire MWI Veterinary Supply, Inc. Jan 26 2015
UPDATE - SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board... Jan 19 2015
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of MWI Veterinary... Jan 16 2015
MWI VETERINARY SUPPLY, INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of MWI... Jan 16 2015
MWI VETERINARY SUPPLY, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of... Jan 16 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK